2 months PFE vs. NVO: Which Stock Is the Better Value Option? Zacks PFE vs. NVO: Which Stock Is the Better Value Option? Pfizer (PFE) · Pharmaceuticals
14 hours Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.Investor's Business Daily
19 hours Marshall Wace LLP Has $37.58 Million Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)MarketBeat
1 day Centessa Pharmaceuticals: Progressing SerpinPC Through Registrational Trials In Hemophilia BSeeking Alpha
2 days Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?Insider Monkey
3 days Catalyst Pharmaceuticals: High Valuation Amid Weak Long-Term Prospects (Rating Downgrade)Seeking Alpha
3 days Pfizer Inc. (NYSE:PFE) to Post Q3 2025 Earnings of $0.72 Per Share, Zacks Research ForecastsMarketBeat
3 days Epoch Investment Partners Inc. Sells 166,411 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)MarketBeat
3 days Tesla Leads S&P 500 Index, While Biotech Giant Tumbles On Court RulingInvestor's Business Daily
5 days Pfizer Inc. (PFE): Strong Q2 2024 Dividend Focus with $5 Billion Returned to ShareholdersInsider Monkey
7 days Apellis Stock Hammered After Eye Drug Gets A Third European RejectionInvestor's Business Daily
1 week Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?Zacks
1 week Jim Cramer Says Regeneron Pharmaceuticals Inc. (REGN)’s Oncology Portfolio is BeautifulInsider Monkey
2 weeks ORIC Pharmaceuticals, Inc. (ORIC): Short Seller Sentiment is Bearish on This Cancer StockInsider Monkey
2 weeks Pfizer says drug for deadly cancer condition that causes weight loss shows positive trial dataCNBC
2 weeks Recursion Pharmaceuticals, Inc. (RXRX): A Very Important AI Stock According to BlackRockInsider Monkey
2 weeks The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart MonopolyThe Wall Street Journal
3 weeks Recursion Pharmaceuticals, Inc. (RXRX): Among the Worst ARK Stocks According to Short SellersInsider Monkey
3 weeks Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?Insider Monkey
3 weeks Regeneron Pharmaceuticals, Inc. (REGN): The Best Biotech Stock According to Hedge Funds?Insider Monkey
3 weeks Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
3 weeks Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
3 weeks Regeneron Pharmaceuticals, Inc. (REGN) Wells Fargo 2024 Healthcare Conference (Transcript)Seeking Alpha
3 weeks Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
3 weeks Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy NowInsider Monkey
3 weeks Crinetics Pharmaceuticals, Inc. (CRNX): Among the Best Mid-Cap Healthcare Stocks To Buy NowInsider Monkey
3 weeks Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy NowInsider Monkey
3 weeks Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I’m Not ConvincedSeeking Alpha
3 weeks Regeneron Pharmaceuticals, Inc. (REGN) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
3 weeks Corbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right NowInsider Monkey
3 weeks Pfizer Inc. (PFE) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
3 weeks Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive MarketInvestor's Business Daily
4 weeks Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short SellersInsider Monkey